Cargando…

Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea

Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Min Sook, Hillen, Jodie, Kang, Dong Yoon, Pratt, Nicole, Shin, Ju-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163376/
https://www.ncbi.nlm.nih.gov/pubmed/35668949
http://dx.doi.org/10.3389/fphar.2022.834116
_version_ 1784719906105720832
author Seo, Min Sook
Hillen, Jodie
Kang, Dong Yoon
Pratt, Nicole
Shin, Ju-Young
author_facet Seo, Min Sook
Hillen, Jodie
Kang, Dong Yoon
Pratt, Nicole
Shin, Ju-Young
author_sort Seo, Min Sook
collection PubMed
description Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our study was conducted to observe prescribing patterns of asthma preventers among paediatric patients specifically focusing on ICSs and LTRAs between Australia and South Korea to see intercountry differences in the use of these medicines. Materials and Methods: The Health Insurance Review and Assessment Paediatric Patients Sample dataset for South Korea and data provided by Services Australia were used in the study. Paediatric patients aged between 3 and 19 with more than one dispensing of an asthma preventer and at least one reliever between 1 Jan 2018 and 31 December 2018 were selected. Prevalence per 1,00,000 persons and standardised prevalence were estimated. Results: A total of 3,58,470 patients (2,04,270 from South Korea and 1,54,200 from Australia) were included in the study. A higher prevalence of ICS-based inhalers was seen in Australia with 80.1% compared to 13.5% in South Korea. In addition, Australia showed a stronger tendency of prescribing high dose ICS-based inhalers compared to South Korea with 22.9% vs. 4.9%. In contrast, use of LTRAs was more prevalent in South Korea with 57.6% while in Australia, montelukast was the only LTRA dispensed at a proportion of 18.9%. Moreover, 29.9% of xanthines which are orally available preventers, were prescribed more frequently in South Korea compared to Australia (0.1%). Conclusion: Australia showed a tendency of prescribing ICS-based preventers whereas South Korea exhibited a preference towards the oral LTRAs. Given the potential risk of neuropsychiatric side effects among paediatric patients with montelukast, reasons for the high use of montelukast in South Korea should be investigated further.
format Online
Article
Text
id pubmed-9163376
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91633762022-06-05 Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea Seo, Min Sook Hillen, Jodie Kang, Dong Yoon Pratt, Nicole Shin, Ju-Young Front Pharmacol Pharmacology Purpose: Inhaled Corticosteroids (ICSs) and oral Leukotriene Receptor Antagonists (LTRAs) are commonly prescribed asthma preventers, however, concerns have been raised as to whether montelukast (LTRA) is associated with an increase in occurrences of neuropsychiatric side effects in children. Our study was conducted to observe prescribing patterns of asthma preventers among paediatric patients specifically focusing on ICSs and LTRAs between Australia and South Korea to see intercountry differences in the use of these medicines. Materials and Methods: The Health Insurance Review and Assessment Paediatric Patients Sample dataset for South Korea and data provided by Services Australia were used in the study. Paediatric patients aged between 3 and 19 with more than one dispensing of an asthma preventer and at least one reliever between 1 Jan 2018 and 31 December 2018 were selected. Prevalence per 1,00,000 persons and standardised prevalence were estimated. Results: A total of 3,58,470 patients (2,04,270 from South Korea and 1,54,200 from Australia) were included in the study. A higher prevalence of ICS-based inhalers was seen in Australia with 80.1% compared to 13.5% in South Korea. In addition, Australia showed a stronger tendency of prescribing high dose ICS-based inhalers compared to South Korea with 22.9% vs. 4.9%. In contrast, use of LTRAs was more prevalent in South Korea with 57.6% while in Australia, montelukast was the only LTRA dispensed at a proportion of 18.9%. Moreover, 29.9% of xanthines which are orally available preventers, were prescribed more frequently in South Korea compared to Australia (0.1%). Conclusion: Australia showed a tendency of prescribing ICS-based preventers whereas South Korea exhibited a preference towards the oral LTRAs. Given the potential risk of neuropsychiatric side effects among paediatric patients with montelukast, reasons for the high use of montelukast in South Korea should be investigated further. Frontiers Media S.A. 2022-05-20 /pmc/articles/PMC9163376/ /pubmed/35668949 http://dx.doi.org/10.3389/fphar.2022.834116 Text en Copyright © 2022 Seo, Hillen, Kang, Pratt and Shin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Seo, Min Sook
Hillen, Jodie
Kang, Dong Yoon
Pratt, Nicole
Shin, Ju-Young
Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title_full Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title_fullStr Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title_full_unstemmed Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title_short Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea
title_sort prescription patterns of asthma preventers among children and adolescents between australia and south korea
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163376/
https://www.ncbi.nlm.nih.gov/pubmed/35668949
http://dx.doi.org/10.3389/fphar.2022.834116
work_keys_str_mv AT seominsook prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea
AT hillenjodie prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea
AT kangdongyoon prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea
AT prattnicole prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea
AT shinjuyoung prescriptionpatternsofasthmapreventersamongchildrenandadolescentsbetweenaustraliaandsouthkorea